A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody"

被引：2
|
作者：
Koizumi, Haruka [1 ]
Muro, Yoshinao [1 ]
Imai, Satoko [1 ]
Yamashita, Yuta [1 ]
Ogawa-Momohara, Mariko [1 ]
Takeichi, Takuya [1 ]
Murakami, Megumi [2 ]
Mitsuma, Teruyuki [2 ]
Akiyama, Masashi [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Dermatol, 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Ichinomiya Municipal Hosp, Dept Dermatol, Ichinomiya, Japan
来源：
JOURNAL OF DERMATOLOGY | 2023年 / 50卷 / 01期
关键词：
AUTOANTIBODIES;
D O I：
10.1111/1346-8138.16587
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E39 / E40
页数：2
相关论文
共 13 条
  • [1] Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
    Zhang, Suo
    Chen, Yu-Lan
    Liu, Cui-Lian
    Xie, Jing-Yi
    Sun, Bao-Dong
    Liu, Dong-Zhou
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Anti-transcription intermediary factor-1γ/α/β antibody-positive dermatomyositis associated with multiple panniculitis lesions
    Yanaba, Koichi
    Tanito, Katsumi
    Hamaguchi, Yasuhito
    Nakagawa, Hidemi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (11) : 1831 - 1834
  • [3] Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis
    Shimizu, Kyoko
    Kobayashi, Tadahiro
    Kano, Miyu
    Hamaguchi, Yasuhito
    Takehara, Kazuhiko
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2020, 47 (01): : 64 - 68
  • [4] Association of serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis
    Li, Xi
    Bai, Jingjing
    Li, Siting
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Qian
    Hu, Chaojun
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 230 - 237
  • [5] Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis
    Ikeda, Nobuaki
    Yamaguchi, Yukie
    Kanaoka, Miwa
    Ototake, Yasushi
    Akita, Asami
    Watanabe, Tomoya
    Aihara, Michiko
    JOURNAL OF DERMATOLOGY, 2020, 47 (05): : 490 - 496
  • [6] Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report
    Kim, Yoonjoo
    Park, Dongil
    Choi, Song-Yi
    Chung, Chaeuk
    THORACIC CANCER, 2022, 13 (19) : 2808 - 2811
  • [7] Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report
    Kim, Yoonjoo
    Chung, Chaeuk
    Park, Dongil
    Choi, Song-Yi
    RESPIROLOGY, 2023, 28 : 295 - 296
  • [8] The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
    Oldroyd, Alexander
    Sergeant, Jamie C.
    New, Paul
    McHugh, Neil J.
    Betteridge, Zoe
    Lamb, Janine A.
    Ollier, William E.
    Cooper, Robert G.
    Chinoy, Hector
    Ahmed, Yasmeen
    Armstrong, Raymond
    Bernstein, Robert
    Black, Carol
    Bowman, Simon
    Bruce, Ian
    Butler, Robin
    Carty, John
    Chattopadhyay, Chandra
    Chelliah, Easwaradhas
    Clarke, Fiona
    Dawes, Peter
    Devlin, Joseph
    Edwards, Christopher
    Emery, Paul
    Fordham, John
    Fraser, Alexander
    Gaston, Hill
    Gordon, Patrick
    Griffiths, Bridget
    Gunawardena, Harsha
    Hall, Frances
    Harrison, Beverley
    Hay, Elaine
    Horden, Lesley
    Isaacs, John
    Jones, Adrian
    Kamath, Sanjeet
    Kennedy, Thomas
    Kitas, George
    Klimiuk, Peter
    Knights, Sally
    Lambert, John
    Lanyon, Peter
    Laxminarayan, Ramasharan
    Lecky, Bryan
    Luqmani, Raashid
    Marks, Jeffrey
    Martin, Michael
    McGonagle, Dennis
    McHugh, Neil
    RHEUMATOLOGY, 2019, 58 (04) : 650 - 655
  • [9] A case of cancer-associated myositis with anti-Mi-2 antibody: False-positive anti-transcriptional intermediary factor 1-γ antibody by commercial enzyme-linked immunosorbent assay
    Nawata, Takashi
    Kubo, Makoto
    Oishi, Keiji
    Murata, Yoriyuki
    Oishi, Mariko
    Okazaki, Yuka
    Omoto, Masatoshi
    Okazaki, Yoshikazu
    Kanda, Takashi
    Kuwana, Masataka
    Yano, Masafumi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1335 - 1339
  • [10] Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker" A case report
    Karino, Kohei
    Fujieda, Yuichiro
    Kawamura, Takuya
    Abe, Nobuya
    Shimoyama, Shuhei
    Kono, Michihito
    Kato, Masaru
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    MEDICINE, 2018, 97 (49)
12